Literature DB >> 7506863

Pharmacological investigations with different protein kinase C inhibitors on IgE-dependent and IgE-independent activation of human basophils.

U Amon1, E von Stebut, H H Wolff.   

Abstract

In the present study different selective inhibitors of the multifunctional serine/threonine kinase protein kinase C (PKC) were investigated on classical activation pathways of basophils in comparison to the nonselective protein kinase inhibitor staurosporine. The potent inhibitors Ro 31-7549, Ro 31-8220, calphostin C and ilmofosine (BM 41.440), which show selectivity for PKC in vitro, significantly potentiated Fc epsilon RI-mediated histamine release up to 50% vs. controls at concentrations > 10(-7) mumol/l but were without any intrinsic histamine releasing activity. Direct activation of cellular PKC by phorbol ester was suppressed by all compounds apart from ilmofosine at the same concentrations. We did not observe statistically significant effects of selective PKC inhibitors on exocytosis induced by the peptide formylmeth-leu-phe (FMLP) or the ionophore A23187, whereas staurosporine potentiated the FMLP-induced histamine release in a dose-dependent fashion: maximum potentiation was 63.5 +/- 8.9% vs. control at 1 mumol/l (n = 4). The findings suggest that PKC exhibits differential functions during biochemical events of stimulus-secretion coupling in human basophils supposedly by its distinct subtypes. With respect to the present data, TPA-induced and IgE-mediated signals are not closely correlated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506863     DOI: 10.1007/bf01975708

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  21 in total

1.  Pharmacological studies on the role of protein kinase C in signal transduction of human basophils.

Authors:  U Amon; E von Stebut; K R Dietz; F W Bauer; H H Wolff
Journal:  Int Arch Allergy Immunol       Date:  1992       Impact factor: 2.749

2.  CGP 41251, a novel protein kinase inhibitor with in vitro selectivity for protein kinase C, strongly inhibits immunological activation of human skin mast cells and human basophils.

Authors:  U Amon; E von Stebut; N Subramanian; H H Wolff
Journal:  Pharmacology       Date:  1993-09       Impact factor: 2.547

3.  Studies of protein kinase C in the rat basophilic leukemia (RBL-2H3) cell reveal that antigen-induced signals are not mimicked by the actions of phorbol myristate acetate and Ca2+ ionophore.

Authors:  J R Cunha-Melo; H M Gonzaga; H Ali; F L Huang; K P Huang; M A Beaven
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

4.  Characteristics of the effect of phorbol ester on rat mast cells: interaction with anti-IgE.

Authors:  M E Cantwell; J C Foreman
Journal:  Agents Actions       Date:  1986-04

Review 5.  The Albert Lasker Medical Awards. The family of protein kinase C for signal transduction.

Authors:  Y Nishizuka
Journal:  JAMA       Date:  1989-10-06       Impact factor: 56.272

Review 6.  Calcium and histamine secretion from mast cells.

Authors:  F L Pearce
Journal:  Prog Med Chem       Date:  1982

7.  Altered leukocyte protein kinase activity in atopic dermatitis.

Authors:  D M Trask; S C Chan; S E Sherman; J M Hanifin
Journal:  J Invest Dermatol       Date:  1988-04       Impact factor: 8.551

8.  Differential mechanisms in the stimulus-secretion coupling in human basophils: evidence for a protein-kinase-C-dependent and a protein-kinase-C-independent route.

Authors:  E F Knol; L Koenderman; E Mul; A J Verhoeven; D Roos
Journal:  Agents Actions       Date:  1990-04

9.  Differential activation of human basophils by anti-IgE and formyl-methionyl-leucyl-phenylalanine. Indications for protein kinase C-dependent and -independent activation pathways.

Authors:  E F Knol; L Koenderman; F P Mul; A J Verhoeven; D Roos
Journal:  Eur J Immunol       Date:  1991-04       Impact factor: 5.532

10.  Influence of protein kinase C activation on basophils from patients with atopic dermatitis in comparison with nonatopic controls.

Authors:  U Amon; E von Stebut; U Ramachers; H H Wolff
Journal:  Dermatology       Date:  1993       Impact factor: 5.366

View more
  1 in total

1.  Investigations with the selective PKC inhibitor chelerythrine on human basophils.

Authors:  E von Stebut; U Amon; J M Herbert; H H Wolff
Journal:  Agents Actions       Date:  1994-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.